B97.29
|
Other coronavirus as the cause of diseases classified elsewhere
|
D80.0
|
Hereditary hypogammaglobulinemia
|
D80.1
|
Nonfamilial hypogammaglobulinemia
|
D80.2
|
Selective deficiency of immunoglobulin A [IgA]
|
D80.3
|
Selective deficiency of immunoglobulin G [IgG] subclasses
|
D80.4
|
Selective deficiency of immunoglobulin M [IgM]
|
D80.5
|
Immunodeficiency with increased immunoglobulin M [IgM]
|
D80.6
|
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
|
D80.8
|
Other immunodeficiencies with predominantly antibody defects
|
D81.0
|
Severe combined immunodeficiency [SCID] with reticular dysgenesis
|
D81.1
|
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
|
D81.2
|
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
|
D81.31
|
Severe combined immunodeficiency due to adenosine deaminase deficiency
|
D81.32
|
Adenosine deaminase 2 deficiency
|
D81.39
|
Other adenosine deaminase deficiency
|
D81.4
|
Nezelof's syndrome
|
D81.5
|
Purine nucleoside phosphorylase [PNP] deficiency
|
D81.6
|
Major histocompatibility complex class I deficiency
|
D81.7
|
Major histocompatibility complex class II deficiency
|
D81.810
|
Biotinidase deficiency
|
D81.818
|
Other biotin-dependent carboxylase deficiency
|
D81.89
|
Other combined immunodeficiencies
|
D82.0
|
Wiskott-Aldrich syndrome
|
D82.1
|
Di George's syndrome
|
D82.2
|
Immunodeficiency with short-limbed stature
|
D82.3
|
Immunodeficiency following hereditary defective response to Epstein-Barr virus
|
D82.4
|
Hyperimmunoglobulin E [IgE] syndrome
|
D82.8
|
Immunodeficiency associated with other specified major defects
|
D83.0
|
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
|
D83.1
|
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
|
D83.2
|
Common variable immunodeficiency with autoantibodies to B- or T-cells
|
D83.8
|
Other common variable immunodeficiencies
|
D84.0
|
Lymphocyte function antigen-1 [LFA-1] defect
|
D84.1
|
Defects in the complement system
|
D89.0
|
Polyclonal hypergammaglobulinemia
|
D89.1
|
Cryoglobulinemia
|
D89.2
|
Hypergammaglobulinemia, unspecified
|
D89.3
|
Immune reconstitution syndrome
|
D89.41
|
Monoclonal mast cell activation syndrome
|
D89.42
|
Idiopathic mast cell activation syndrome
|
D89.43
|
Secondary mast cell activation
|
D89.49
|
Other mast cell activation disorder
|
D89.810
|
Acute graft-versus-host disease
|
D89.811
|
Chronic graft-versus-host disease
|
D89.812
|
Acute on chronic graft-versus-host disease
|
D89.82
|
Autoimmune lymphoproliferative syndrome [ALPS]
|
D89.89
|
Other specified disorders involving the immune mechanism, not elsewhere classified
|
E84.0
|
Cystic fibrosis with pulmonary manifestations
|
E84.19
|
Cystic fibrosis with other intestinal manifestations
|
E84.8
|
Cystic fibrosis with other manifestations
|
I27.0
|
Primary pulmonary hypertension
|
I27.21
|
Secondary pulmonary arterial hypertension
|
I27.22
|
Pulmonary hypertension due to left heart disease
|
I27.23
|
Pulmonary hypertension due to lung diseases and hypoxia
|
I27.24
|
Chronic thromboembolic pulmonary hypertension
|
I27.29
|
Other secondary pulmonary hypertension
|
I27.81
|
Cor pulmonale (chronic)
|
I27.82
|
Chronic pulmonary embolism
|
I27.83
|
Eisenmenger's syndrome
|
I27.89
|
Other specified pulmonary heart diseases
|
I50.21
|
Acute systolic (congestive) heart failure
|
I50.22
|
Chronic systolic (congestive) heart failure
|
I50.23
|
Acute on chronic systolic (congestive) heart failure
|
I50.31
|
Acute diastolic (congestive) heart failure
|
I50.32
|
Chronic diastolic (congestive) heart failure
|
I50.33
|
Acute on chronic diastolic (congestive) heart failure
|
I50.41
|
Acute combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.42
|
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.43
|
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
|
I50.811
|
Acute right heart failure
|
I50.812
|
Chronic right heart failure
|
I50.813
|
Acute on chronic right heart failure
|
I50.814
|
Right heart failure due to left heart failure
|
I50.82
|
Biventricular heart failure
|
I50.83
|
High output heart failure
|
I50.84
|
End stage heart failure
|
I50.89
|
Other heart failure
|
J00
|
Acute nasopharyngitis [common cold]
|
J02.9
|
Acute pharyngitis, unspecified
|
J04.0
|
Acute laryngitis
|
J04.10
|
Acute tracheitis without obstruction
|
J04.11
|
Acute tracheitis with obstruction
|
J04.2
|
Acute laryngotracheitis
|
J04.30
|
Supraglottitis, unspecified, without obstruction
|
J04.31
|
Supraglottitis, unspecified, with obstruction
|
J05.0
|
Acute obstructive laryngitis [croup]
|
J05.10
|
Acute epiglottitis without obstruction
|
J05.11
|
Acute epiglottitis with obstruction
|
J06.0
|
Acute laryngopharyngitis
|
J06.9
|
Acute upper respiratory infection, unspecified
|
J09.X1
|
Influenza due to identified novel influenza A virus with pneumonia
|
J09.X2
|
Influenza due to identified novel influenza A virus with other respiratory manifestations
|
J09.X3
|
Influenza due to identified novel influenza A virus with gastrointestinal manifestations
|
J09.X9
|
Influenza due to identified novel influenza A virus with other manifestations
|
J12.0
|
Adenoviral pneumonia
|
J12.3
|
Human metapneumovirus pneumonia
|
J12.81
|
Pneumonia due to SARS-associated coronavirus
|
J12.82*
|
Pneumonia due to coronavirus disease 2019
|
J12.89
|
Other viral pneumonia
|
J12.9
|
Viral pneumonia, unspecified
|
J15.8
|
Pneumonia due to other specified bacteria
|
J16.8
|
Pneumonia due to other specified infectious organisms
|
J18.0
|
Bronchopneumonia, unspecified organism
|
J18.1
|
Lobar pneumonia, unspecified organism
|
J18.2
|
Hypostatic pneumonia, unspecified organism
|
J18.8
|
Other pneumonia, unspecified organism
|
J18.9
|
Pneumonia, unspecified organism
|
J20.8
|
Acute bronchitis due to other specified organisms
|
J22
|
Unspecified acute lower respiratory infection
|
J41.0
|
Simple chronic bronchitis
|
J41.1
|
Mucopurulent chronic bronchitis
|
J41.8
|
Mixed simple and mucopurulent chronic bronchitis
|
J43.0
|
Unilateral pulmonary emphysema [MacLeod's syndrome]
|
J43.1
|
Panlobular emphysema
|
J43.2
|
Centrilobular emphysema
|
J43.8
|
Other emphysema
|
J44.0
|
Chronic obstructive pulmonary disease with (acute) lower respiratory infection
|
J44.1
|
Chronic obstructive pulmonary disease with (acute) exacerbation
|
J45.21
|
Mild intermittent asthma with (acute) exacerbation
|
J45.22
|
Mild intermittent asthma with status asthmaticus
|
J45.30
|
Mild persistent asthma, uncomplicated
|
J45.31
|
Mild persistent asthma with (acute) exacerbation
|
J45.32
|
Mild persistent asthma with status asthmaticus
|
J45.40
|
Moderate persistent asthma, uncomplicated
|
J45.41
|
Moderate persistent asthma with (acute) exacerbation
|
J45.42
|
Moderate persistent asthma with status asthmaticus
|
J45.50
|
Severe persistent asthma, uncomplicated
|
J45.51
|
Severe persistent asthma with (acute) exacerbation
|
J45.52
|
Severe persistent asthma with status asthmaticus
|
J45.991
|
Cough variant asthma
|
J45.998
|
Other asthma
|
J47.0
|
Bronchiectasis with acute lower respiratory infection
|
J47.1
|
Bronchiectasis with (acute) exacerbation
|
J47.9
|
Bronchiectasis, uncomplicated
|
J60
|
Coalworker's pneumoconiosis
|
J61
|
Pneumoconiosis due to asbestos and other mineral fibers
|
J62.0
|
Pneumoconiosis due to talc dust
|
J62.8
|
Pneumoconiosis due to other dust containing silica
|
J63.0
|
Aluminosis (of lung)
|
J63.1
|
Bauxite fibrosis (of lung)
|
J63.2
|
Berylliosis
|
J63.3
|
Graphite fibrosis (of lung)
|
J63.4
|
Siderosis
|
J63.5
|
Stannosis
|
J63.6
|
Pneumoconiosis due to other specified inorganic dusts
|
J65
|
Pneumoconiosis associated with tuberculosis
|
J66.0
|
Byssinosis
|
J66.1
|
Flax-dressers' disease
|
J66.2
|
Cannabinosis
|
J66.8
|
Airway disease due to other specific organic dusts
|
J70.1
|
Chronic and other pulmonary manifestations due to radiation
|
J70.3
|
Chronic drug-induced interstitial lung disorders
|
J81.1
|
Chronic pulmonary edema
|
J84.10
|
Pulmonary fibrosis, unspecified
|
J84.111
|
Idiopathic interstitial pneumonia, not otherwise specified
|
J84.112
|
Idiopathic pulmonary fibrosis
|
J84.113
|
Idiopathic non-specific interstitial pneumonitis
|
J84.114
|
Acute interstitial pneumonitis
|
J84.115
|
Respiratory bronchiolitis interstitial lung disease
|
J84.116
|
Cryptogenic organizing pneumonia
|
J84.117
|
Desquamative interstitial pneumonia
|
J84.170
|
Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere
|
J84.178
|
Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere
|
J84.2
|
Lymphoid interstitial pneumonia
|
J84.81
|
Lymphangioleiomyomatosis
|
J84.82
|
Adult pulmonary Langerhans cell histiocytosis
|
J84.89
|
Other specified interstitial pulmonary diseases
|
J84.9
|
Interstitial pulmonary disease, unspecified
|
R04.2
|
Hemoptysis
|
R05.1
|
Acute cough
|
R05.2
|
Subacute cough
|
R06.02
|
Shortness of breath
|
R06.03
|
Acute respiratory distress
|
R06.1
|
Stridor
|
R06.2
|
Wheezing
|
R06.82
|
Tachypnea, not elsewhere classified
|
R07.1
|
Chest pain on breathing
|
R07.81
|
Pleurodynia
|
R09.02
|
Hypoxemia
|
R09.1
|
Pleurisy
|
R43.0
|
Anosmia
|
R43.9
|
Unspecified disturbances of smell and taste
|
R50.81
|
Fever presenting with conditions classified elsewhere
|
R50.9
|
Fever, unspecified
|
R53.1
|
Weakness
|
R55
|
Syncope and collapse
|
R68.83
|
Chills (without fever)
|
R79.81
|
Abnormal blood-gas level
|
Z03.818
|
Encounter for observation for suspected exposure to other biological agents ruled out
|
Z20.822
|
Contact with and (suspected) exposure to COVID-19
|
Z20.828
|
Contact with and (suspected) exposure to other viral communicable diseases
|
U07.1
|
COVID-19
|